{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,9]],"date-time":"2026-07-09T05:38:55Z","timestamp":1783575535090,"version":"3.55.0"},"reference-count":22,"publisher":"BMJ","issue":"4","license":[{"start":{"date-parts":[[2022,3,7]],"date-time":"2022-03-07T00:00:00Z","timestamp":1646611200000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"name":"Beijing Hospitals Authority Youth Programme","award":["QML20190501"],"award-info":[{"award-number":["QML20190501"]}]},{"DOI":"10.13039\/501100012166","name":"National Key R&D Program of China","doi-asserted-by":"crossref","award":["2018YFC1312903"],"award-info":[{"award-number":["2018YFC1312903"]}],"id":[{"id":"10.13039\/501100012166","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100009592","name":"Beijing Municipal Science & Technology Commission","doi-asserted-by":"crossref","award":["D171100003017002"],"award-info":[{"award-number":["D171100003017002"]}],"id":[{"id":"10.13039\/501100009592","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100009592","name":"Beijing Municipal Science & Technology Commission","doi-asserted-by":"crossref","award":["Z181100001818001"],"award-info":[{"award-number":["Z181100001818001"]}],"id":[{"id":"10.13039\/501100009592","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81870905"],"award-info":[{"award-number":["81870905"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81971091"],"award-info":[{"award-number":["81971091"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["U20A20358"],"award-info":[{"award-number":["U20A20358"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["Stroke Vasc Neurol"],"accepted":{"date-parts":[[2022,1,15]]},"published-print":{"date-parts":[[2022,8]]},"abstract":"<jats:sec>\n                  <jats:title>Background and purpose<\/jats:title>\n                  <jats:p>Dyslipidaemia is a major risk factor for ischaemic stroke and transient ischaemic attack (TIA). This study aimed to investigate the association between baseline low-density lipoprotein cholesterol (LDL-C) level, lipid-lowering treatment and short-term risk of new stroke in patients with a minor ischaemic stroke or TIA.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Methods<\/jats:title>\n                  <jats:p>We derived data from the Clopidogrel in High-risk patients with Acute Non-disabling Cerebrovascular Events trial. Patients with a minor stroke or TIA were categorised by LDL-C level at baseline (&lt;2.6\u2009or \u22652.6\u2009mmol\/L (100\u2009mg\/dL)) and with or without lipid-lowering treatment after symptom onset. The primary outcome was a new ischaemic stroke at 3 months. The association of baseline LDL-C level, lowering treatment and outcomes were assessed.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Results<\/jats:title>\n                  <jats:p>Among 3027 patients, 2154 (71.2%) patients had an initial LDL-C \u22652.6\u2009mmol\/L, of which 1267 (41.9%) received lipid-lowering treatment. Elevated LDL-C level was associated with a higher risk of new ischaemic stroke at 3 months in patients without lipid-lowering treatment (adj.HR=1.35, 95%\u2009CI: 1.19 to 1.53), but not in those with lipid-lowering treatment (adj.HR=0.99, 95%\u2009CI: 0.82 to 1.19) (p for interaction=0.007). Patients with LDL-C \u22652.6\u2009mmol\/L had a numerically higher risk of ischaemic stroke (11.8% vs 8.0%, adj.HR=1.37, 95%\u2009CI: 0.96 to 1.96) in those without lipid-lowering treatment. For patients with LDL-C \u22652.6\u2009mmol\/L, lipid-lowering treatment was associated with reduced risk of ischaemic stroke at 3 months (7.9% vs 11.8%; adj.HR=0.54, 95%\u2009CI: 0.39 to 0.75).<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Conclusions<\/jats:title>\n                  <jats:p>Elevated untreated baseline LDL-C level was associated with an increased short-term risk of ischaemic stroke among patients presenting with minor ischaemic stroke or TIA. There was potential benefit of lipid-lowering treatment in minor stroke or TIA patients with LDL-C \u22652.6\u2009mmol\/L.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Trial registration number<\/jats:title>\n                  <jats:p>\n                     <jats:ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"clintrialgov\" xlink:href=\"NCT00979589\">NCT00979589<\/jats:ext-link>.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1136\/svn-2021-001317","type":"journal-article","created":{"date-parts":[[2022,9,2]],"date-time":"2022-09-02T09:20:10Z","timestamp":1662110410000},"page":"276-284","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":24,"title":["LDL-C levels, lipid-lowering treatment and recurrent stroke in minor ischaemic stroke or TIA"],"prefix":"10.1136","volume":"7","clinical-trial-number":[{"clinical-trial-number":"nct00979589","registry":"10.18810\/clinical-trials-gov"}],"author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3082-6789","authenticated-orcid":false,"given":"Yuesong","family":"Pan","sequence":"first","affiliation":[{"name":"Department of Neurology, Beijing Tiantan Hospital, Capital Medical University, Beijing, China"},{"name":"China National Clinical Research Center for Neurological Diseases, Beijing, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8069-3676","authenticated-orcid":false,"given":"Runqi","family":"Wangqin","sequence":"additional","affiliation":[{"name":"Department of Neurology, Duke University Medical Center, Durham, NC, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8591-4105","authenticated-orcid":false,"given":"Hao","family":"Li","sequence":"additional","affiliation":[{"name":"Department of Neurology, Beijing Tiantan Hospital, Capital Medical University, Beijing, China"},{"name":"China National Clinical Research Center for Neurological Diseases, Beijing, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aoming","family":"Jin","sequence":"additional","affiliation":[{"name":"Department of Neurology, Beijing Tiantan Hospital, Capital Medical University, Beijing, China"},{"name":"China National Clinical Research Center for Neurological Diseases, Beijing, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2415-4843","authenticated-orcid":false,"given":"Jiejie","family":"Li","sequence":"additional","affiliation":[{"name":"Department of Neurology, Beijing Tiantan Hospital, Capital Medical University, Beijing, China"},{"name":"China National Clinical Research Center for Neurological Diseases, Beijing, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jinxi","family":"Lin","sequence":"additional","affiliation":[{"name":"Department of Neurology, Beijing Tiantan Hospital, Capital Medical University, Beijing, China"},{"name":"China National Clinical Research Center for Neurological Diseases, Beijing, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xia","family":"Meng","sequence":"additional","affiliation":[{"name":"Department of Neurology, Beijing Tiantan Hospital, Capital Medical University, Beijing, China"},{"name":"China National Clinical Research Center for Neurological Diseases, Beijing, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ying","family":"Xian","sequence":"additional","affiliation":[{"name":"Department of Neurology, UT Southwestern Medical Center, Dallas, Texas, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel T","family":"Laskowitz","sequence":"additional","affiliation":[{"name":"Department of Neurology, Duke University Medical Center, Durham, NC, USA"},{"name":"Duke Clinical Research Institute, Durham, North Carolina, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yongjun","family":"Wang","sequence":"additional","affiliation":[{"name":"Department of Neurology, Beijing Tiantan Hospital, Capital Medical University, Beijing, China"},{"name":"China National Clinical Research Center for Neurological Diseases, Beijing, China"},{"name":"Advanced Innovation Center for Human Brain Protection, Capital Medical University, Beijing, China"},{"name":"Center for Excellence in Brain Science and Intelligence Technology, Chinese Academy of Sciences, Shanghai, China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"239","published-online":{"date-parts":[[2022,3,7]]},"reference":[{"key":"2025082410550947000_7.4.276.1","doi-asserted-by":"publisher","DOI":"10.1016\/j.atherosclerosis.2019.12.005"},{"key":"2025082410550947000_7.4.276.2","doi-asserted-by":"publisher","DOI":"10.1136\/svn-2020-000378"},{"key":"2025082410550947000_7.4.276.3","doi-asserted-by":"publisher","DOI":"10.1136\/svn-2020-000457"},{"key":"2025082410550947000_7.4.276.4","doi-asserted-by":"crossref","first-page":"1637","DOI":"10.1016\/S0140-6736(20)32332-1","article-title":"Efficacy and safety of lowering LDL cholesterol in older patients: a systematic review and meta-analysis of randomised controlled trials","volume":"396","author":"Gencer","year":"2020","journal-title":"Lancet"},{"key":"2025082410550947000_7.4.276.5","doi-asserted-by":"publisher","DOI":"10.1212\/wnl.0000000000007091"},{"key":"2025082410550947000_7.4.276.6","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2020.07.033"},{"key":"2025082410550947000_7.4.276.7","doi-asserted-by":"publisher","DOI":"10.1161\/STROKEAHA.119.026402"},{"key":"2025082410550947000_7.4.276.8","doi-asserted-by":"publisher","DOI":"10.1038\/s41591-019-0366-x"},{"key":"2025082410550947000_7.4.276.9","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa061894"},{"key":"2025082410550947000_7.4.276.10","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1910355"},{"key":"2025082410550947000_7.4.276.11","doi-asserted-by":"publisher","DOI":"10.1016\/j.ahj.2010.05.017"},{"key":"2025082410550947000_7.4.276.12","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1215340"},{"key":"2025082410550947000_7.4.276.13","doi-asserted-by":"crossref","first-page":"1330","DOI":"10.1212\/WNL.0000000000001421","article-title":"Glycated albumin predicts the effect of dual and single antiplatelet therapy on recurrent stroke","volume":"84","author":"Li","year":"2015","journal-title":"Neurology"},{"key":"2025082410550947000_7.4.276.14","first-page":"937","article-title":"Guidelines for the prevention and treatment of adult dyslipidemia in China (revised in 2016) (in Chinese)","volume":"31","year":"2016","journal-title":"Chinese Circulation Journal"},{"key":"2025082410550947000_7.4.276.15","doi-asserted-by":"publisher","DOI":"10.1093\/aje\/kwj047"},{"key":"2025082410550947000_7.4.276.16","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1161\/CIRCULATIONAHA.120.046774","article-title":"Carotid atherosclerosis evolution when targeting a low-density lipoprotein cholesterol concentration <70 mg\/dl after an ischemic stroke of atherosclerotic origin","volume":"142","author":"Amarenco","year":"2020","journal-title":"Circulation"},{"key":"2025082410550947000_7.4.276.17","doi-asserted-by":"publisher","DOI":"10.1136\/jnnp-2019-320893"},{"key":"2025082410550947000_7.4.276.18","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1801174"},{"key":"2025082410550947000_7.4.276.19","doi-asserted-by":"crossref","first-page":"51","DOI":"10.5853\/jos.2020.03391","article-title":"Residual risk and its risk factors for ischemic stroke with adherence to Guideline-Based secondary stroke prevention","volume":"23","author":"Pan","year":"2021","journal-title":"J Stroke"},{"key":"2025082410550947000_7.4.276.20","doi-asserted-by":"publisher","DOI":"10.1179\/1743132812Y.0000000107"},{"key":"2025082410550947000_7.4.276.21","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0084389","article-title":"Association between statin use and short-term outcome based on severity of ischemic stroke: a cohort study","volume":"9","author":"Song","year":"2014","journal-title":"PLoS One"},{"key":"2025082410550947000_7.4.276.22","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1001\/jama.2020.25071","article-title":"Incidence of transient ischemic attack and association with long-term risk of stroke","volume":"325","author":"Lioutas","year":"2021","journal-title":"JAMA"}],"container-title":["Stroke and Vascular Neurology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/svn-2021-001317","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,8,24]],"date-time":"2025-08-24T17:55:21Z","timestamp":1756058121000},"score":1,"resource":{"primary":{"URL":"https:\/\/svn.bmj.com\/lookup\/doi\/10.1136\/svn-2021-001317"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,3,7]]},"references-count":22,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2022,9,2]]},"published-print":{"date-parts":[[2022,8]]}},"alternative-id":["10.1136\/svn-2021-001317"],"URL":"https:\/\/doi.org\/10.1136\/svn-2021-001317","relation":{},"ISSN":["2059-8688","2059-8696"],"issn-type":[{"value":"2059-8688","type":"print"},{"value":"2059-8696","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,3,7]]}}}